Jenburkt Pharmaceuticals Ltd — Updates, 23-06-2025: Company Update

Jenburkt Pharmaceuticals Limited has announced a board meeting to approve the financial results for the quarter and half-year. The company has completed dispatch of its Annual Report and notice for the 40th Annual General Meeting (AGM), which will be held via video conferencing. Members can participate and vote electronically through remote e-voting prior to the AGM or via e-voting during the meeting. Shareholders are encouraged to update their PAN, email, and bank details for smooth communication and dividend transfers. This digital approach aims to ensure broad shareholder participation and regulatory compliance.